K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Senior Vice President - Clinical Development

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • At least 15 years of clinical development experience, with a proven track record of executing clinical trials and global regulatory interactions.
  • Significant late-stage development experience across large-scale, complex programs.
  • Prior leadership, budgeting, and resource management experience.
  • Ability to travel by air as necessary to perform the role.
  • MD or equivalent.
  • Remote employees must follow the Hub & Home model, including spending at least one week per month in the Waltham, Massachusetts corporate office, in addition to other work-related travel; overall work-related travel is estimated at least 25%.

Responsibilities

  • Lead the development, execution, and communication of global medical and scientific evidence-generation strategy for products; incorporate cross-functional input, translate the strategy into an aligned vision and actionable global development plan, and be accountable for execution.
  • Develop key external scientific relationships with leaders in the obesity research and medical community, interact with global regulatory authorities, and work cross-functionally within the medical organization and throughout the company.
  • Build, grow, and lead the global clinical development organization.
  • Develop and execute global development strategy and the resulting evidence-generation plan, incorporating cross-functional and regional input.
  • Design, execute, complete, and communicate clinical trials, including scientific advisory boards, protocol development, regulatory and ethics committee interactions, medical monitoring, data analyses, study reports, regulatory correspondence and filings, presentations, and data dissemination.
  • Deliver robust clinical-trial data on time and on budget to inform product benefit-risk.
  • Interface with global medical opinion leaders in obesity to inform the clinical development program and maintain engagement.
  • Communicate clearly, using data and a patient-focused approach, with global regulators.
  • Provide clinical input to regulatory, safety, medical affairs, commercial, payer, and manufacturing colleagues.

Desired Qualifications

  • Experience in obesity and/or metabolic disease is strongly preferred.
  • Local candidates are strongly preferred; relocation and remote talent will be considered.
  • Exceptional cross-functional communication skills and the ability to influence and lead across diverse stakeholders.
  • A drive for problem solving, continual learning, and attracting, mentoring, and retaining the best people.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs